KATELYN LYNCH: Open Payments
NPI 1194977330 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 29 payments from 19 companies in 2025. Trend: 2023 $2,173 · 2024 $333 · 2025 $1,463
Food & beverage: $995Consulting: $425Education: $43
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 4 | $628 |
| Medtronic, Inc. | 3 | $262 |
| Dexcom, Inc. | 1 | $149 |
| Abbott Laboratories | 4 | $79 |
| Ascendis Pharma Endocrinology Inc | 2 | $45 |
| Mannkind Corporation | 1 | $43 |
| Novo Nordisk Inc | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| RGH Enterprises LLC | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $22 |
Products named: STRENSIQ, MINIMED 780G, DEXCOM G7 GSS (161), FREESTYLE LIBRE 3, Yorvipath, AFREZZA, CRENESSITY, TWIIST.
Industry payments across MI — which companies pay providers there.
